Alnylam pharmaceuticals reports third quarter 2020 financial results and highlights recent period activity

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, today reported its consolidated financial results for the third quarter 2020 and reviewed recent business highlights. “we are extremely pleased with the performance of onpattro and givlaari in the third quarter, reflecting strong commercial execution and improving market conditions following the more challenging covid-19 pandemic phase experienced in the second quarter. we're
ALNY Ratings Summary
ALNY Quant Ranking